Pharmacological Treatment Of Osteoarthritis In A Nutshell
DOI:
https://doi.org/10.51985/JBUMDC2018084Keywords:
osteoarthritis, treatment, pharmacological modalities, conservativeAbstract
Osteoarthritis, an inflammatory, degenerative disease of joints mostly affects weight bearing joints in old age. Treatment
modalities are categorized into non-pharmacological, pharmacological and surgical. Among pharmacological options, oral
formulations are mostly used. Acetaminophen is considered as first line though, NSAIDs are well established choice for
the management of osteoarthritis and mostly employed for the same. However NSAIDs are associated with gastric adverse
effects. Symptomatic slow acting osteoarthritis drugs like glucosamine, chondroitin sulfate, diacerein and avocado soybean
saponifiables are considered as maintenance therapy as they have shown to reserve joint space width. Topical formulations
are good for patients with co-morbidities. For patient not responding to other modalities, opioids and duloxetine are
employed but with caution. Intra-articular injections like corticosteroids, hyaluronic acid and Platelet rich plasma are ranked
highest in efficacy. Newer agents like Nerve growth factor- inhibitors, Interleukin-1 antagonists and certain neutraceutical
preparations are under investigation for osteoarthritis management.
References
Bobacz K. Pharmacologic treatment of hand- , knee- and hip-osteoarthritis. Wien Med Wochenschr. 2013; 163:236–42.
Mobasheri A, Bay-jensen A, Spil WE Van, Larkin J, Levesque MC. Osteoarthritis Year in Review 2016?: biomarkers ( biochemical markers ). Osteoarth Cartil. 2017; 25:199–208.
BijlsmaJW, BerenbaumF, LafeberFP. Osteoarthritis:an update with relevance for clinical practice. The Lancet. 2011; 377:2115–26.
Birtwhistle R, Morkem R, Peat G, Williamson T, Green ME, Khan S et al. Prevalence and management of osteoarthritis in primary care: an epidemiologic cohort study from the Canadian Primary Care Sentinel Surveillance Network. CMAJ. 2015; 3(3): E270–5.
WHO / chronic rheumatic conditions, http://www.who. int/chp/topics/rheumatic/en/ (accessed on 15-07-2018)
Akhter E, Bilal S, Haque U. Prevalence of arthritis in India and Pakistan: A review. Rheumatol Int. 2011;31(7):849–55.
Zweers MC, Boer TN De, Roon J Van, Bijlsma JWJ, Lafeber FPJG, Mastbergen SC. Celecoxib?: considerations regarding its potential disease-modifying properties in osteoarthritis. Arthritis Res Ther. 2011;13(5): 239-50
Vincent TL, Watt FE. Osteoarthritis. Medicine 2014;42 (4),213–9.
Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: Estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(7):1323–30.
Zhang Y, Jordan JM. Epidemiology of Osteoarthritis. Clin Geriatr Med.2010; 26(3):355–69.
Braun HJ, Gold GE. Diagnosis of osteoarthritis: imaging. Bone. 2012;51(2):278-88.
Kellgren JH, Lawrence JS. Radiological assessment of osteoarthritis. Ann rheum Dis. 1956; 16(3):494–503.
Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986; 29: 1039-49.
Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum . 1991;34:505–14.
Altman R., Alarcon G., Appelrouth D., Bloch D., Borenstein D., Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum, 1990;33(11),1601-10.
NICE. Osteoarthritis: care and management Clinical guideline. 2014;(February 2014). nice.org.uk/guidance/cg177
McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014;22(3):363–88
Geenen R, Overman CL, Christensen R, Åsenlöf P, Capela S, Huisinga KL, et al. EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis. 2018;77 (6):797–807.
Machado GC, Maher CG, Ferreira PH, Pinheiro MB, Lin C-WC, Day RO et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015; 350:h1225
Stewart M, Cibere J, Sayre EC, Kopec JA. Efficacy of commonly prescribed analgesics in the management of osteoarthritis: a systematic review and meta-analysis. Rheumatol Int. 2018; doi: 10.1007/s00296-018-4132-z.
Craig DGN, Bates CM, Davidson JS, Martin KG, Hayes PC, Simpson KJ Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity: outcomes following staggered and delayed paracetamol overdose. Br J Clin Pharmacol. 2012;73(2): 285-94
Prior MJ, Harrison DD. 12 week trial of acetaminophen extended release for the treatment of signs and symptoms of osteoarthritis. Curr Med Res Opin. 2014;30(11):2377–87.
Robert J. Holt, John G. Fort, Amy Y. Grahn, Jeffrey D. Kent & Alfonso E. Bello Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib. Physi Sportsmed. 2015;43(3) 200-12.
Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Jüni P, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis?: a network meta-analysis. The Lancet. 2017; 387(10033) 2093–105.
Song GG, Seo YH, Kim J-H, Choi SJ, Ji JD, Lee YH. Relative efficacy and tolerability of etoricoxib, celecoxib, and naproxen in the treatment of osteoarthritis. Z Rheumatol. 2016;75(5): 508–16.
Massó González EL, Patrignani P, Tacconelli S, García Rodríguez LA. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum. 2010;62(6):1592–601.
Lanza FL, Chan FK, Quigley EMM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009;104(3):728–38.
Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Bhala N, Emberson J, Merhi A, Abramson S, Arber N, et al. Vascular and upper GI effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomized trials. The Lancet 2013;382(9894): 769–79
Kongtharvonskul J, Anothaisintawee T, McEvoy M, Attia J, Woratanarat P, Thakkinstian A. Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: A systematic review and network meta-analysis. Eur J Med Res. 2015;20(1):1–11
Zhu X, Sang L, Wu D, Rong J, Jiang L. Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis?: a meta-analysis of randomized controlled trials. J Orthop Surg Med.2018;13(1);170.
Fransen M, Agaliotis M, Nairn L, Votrubec M, Bridgett L, Su S,et al. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis 2015;74(5):851-8.
Lane NE, Shidara K, Wise BL. Osteoarthritis year in review 2016?: clinical. Osteoarthr Cartil. 2017;25(2):209–15.
Brandt KD, Smith G, Kang SY, Myers S, O’Connor B, Albrecht M. Effects of diacerhein in an accelerated canine model of osteoarthritis. Osteoarthr Cartil. 1997;5:438–49.
Bartels EM, Bliddal H, Schondorff PK, Altman RD, Zhang W, Christensen R. Symptomatic efficacy and safety of diacerein in the treatment of : a meta-analysis of randomized placebo-controlled trials. Osteoarthr Cartil. 2010; 18(3):289–96. doi:10.1016/j.joca.2009.10.006.
Pavelka K, Bruyère O, Cooper C, Kanis JA, Leeb BF, Maheu E, et al. Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO. Drugs & Aging. 2016; 33(2): 75-85.
Christiansen BA, Bhatti S, Goudarzi R, Emami S. Management of Osteoarthritis with Avocado / Soybean Unsaponifiables. Curr Med Res Opin 2015; 6(1),30-44
Maheu E, Cadet C, Marty M, Moyse D, Kerloch I, Coste P, et al. Randomised , controlled trial of avocado – soybean unsaponifiable ( Piascledine ) effect on structure modi fi cation in hip osteoarthritis?: the ERADIAS study. Ann Rheum Dis. 2014;73(2):376–84.
Hitzeman N, Athale N. Opioids for osteoarthritis of the knee or Hip. Am Fam Physician. 2010;81(9):1094–6.
Williamson OD, Schroer M, Ruff DD, Ahl J, Margherita A, Sagman D, et al. Onset of response with duloxetine treatment in patients with osteoarthritis knee pain and chronic low back pain: A post hoc analysis of placebo-controlled trials. Clin Ther. 2014;36(4):544–51.
Wang ZY, Shi SY, Li SJ, Chen F, Chen H, Lin HZ, et al. Efficacy and Safety of Duloxetine on Osteoarthritis Knee Pain: A Meta-Analysis of Randomized Controlled Trials. Pain Med. 2015;16(7):1373–85.
Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.Arthritis Care Res. 2012;64(4):465–74
Meng Z, Huang R. Topical treatment of degenerative knee osteoarthritis. Am J Med Sci. 2017; 355(1): 6-12.
Altman RD, Barthel HR. Topical Therapies for Osteoarthritis. Drugs. 2011;71(10):1259–79.
Guedes V, Paulo J, Brito I. Topical capsaicin for pain in osteoarthritis: A literature review. Reumatol Clínica. 2018;14(1):40-45.
Hameed F, Ihm J. Injectable medications for osteoarthritis. PMRJ. 2012;4 (Suppl 5):S75–81.
Jüni P, Hari R, Aws R, Fischer R, Mg S, Reichenbach S, et al. Intra-articular corticosteroid for knee osteoarthritis (review) summary of findings for the main comparison. Cochrane Database Syst Rev. 2015;(10):2–3.
Cheng OT, Souzdalnitski D, Vrooman B, et al. Evidence-based knee injections for the management of arthritis. Pain Med. 2012;13(6):740–53.
Cole BJ, Verma NN. Is Local Viscosupplementation Injection Clinically Superior to Other Therapies in the Treatment of Osteoarthritis of the Knee?: A Systematic Review of Overlapping Meta-analyses. Arthrosc J Arthrosc Relat Surg. 2015;31(10):2036–2045.
Traucy-Uy RL, Lynch SA. Diagnosis and Treatment of Osteoarthritis. Prim Care Clin Off Pract . 2013; 40(4):821-836.
Smith C, Patel R, Vannabouathong C, Sales B, Rabinovich A, Mccormack R, et al. Combined intra-articular injection of corticosteroid and hyaluronic acid reduces pain compared to hyaluronic acid alone in the treatment of knee osteoarthritis. Knee Surg Sport Traumatol Arthrosc. 2018; doi: 10.1007/s00167-018-5071-7.
Dai WL, Zhuo AG, Zhang H, Zhang J. Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials. Artho. 2016; 33(3)659-70.
Di Y, Han C, Zhao L, Ren Y. Is local platelet-rich plasma injection clinically superior to hyaluronic acid for treatment of knee osteoarthritis?? A systematic review of randomized controlled trials. Arthritis Res Ther. 2018;20(1): 128.
Vannabouathong C. Nonoperative Treatments for Knee Osteoarthritis: An Evaluation of Treatment Characteristics and the Intra-Articular Placebo Effect. JBJS Rev. 2018;6(7):e5.
Therkleson T. Topical ginger treatment with a compress or patch for osteoarthritis symptoms. J Holist Nurs. 2014;32(3)173–82.
Bartels EM, Folmer VN, Bliddal H, Altman RD, Juhl C, Tarp S, et al. Efficacy and safety of ginger in osteoarthritis patients: A meta-analysis of randomized placebo-controlled trials. Osteoarthr Cartil .2015;23(1):13–21
Lubis AMT, Siagian C, Wonggokusuma E, Marsetio AF. Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis?: A Double Blind Randomized Controlled Trial. Acta Med Indones. 2017;49(2):105–11.
Chevalier X, Eymard F, Richette P. Biologic agents in osteoarthritis: hopes and disappointments. Nat Rev Rheumatol. 2013;9(7):400-10.
Yang KG, Raijmakers NJ, van Arkel ER, Caron JJ, Rijk PC, Willems WJ, et al. Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial. Osteoarth Cartil. 2008;16(4):498-505.
Smelter E, Hochberg MC. New treatments for osteoarthritis. Curr Opin Rheumatol. 2013;25(3):310-6.
Bruyere O, Reginster JY, Bellamy N, Chapurlat R, Richette P, Cooper C. Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis. Rheum (Oxford). 2014;53(8):1457-64.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Journal of Bahria University Medical and Dental College
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
